Philadelphia Trust CO Regeneron Pharmaceuticals, Inc. Transaction History

Philadelphia Trust CO

  • $1.38 Billion
  • Q3 2024

A detailed history of Philadelphia Trust CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Philadelphia Trust CO holds 2,415 shares of REGN stock, worth $1.78 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
2,415
Previous 1,165 107.3%
Holding current value
$1.78 Million
Previous $1.22 Million 107.43%
% of portfolio
0.18%
Previous 0.1%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$1024.09 - $1201.76 $1.28 Million - $1.5 Million
1,250 Added 107.3%
2,415 $2.54 Million
Q2 2024

Aug 13, 2024
SELL
$883.2 - $1071.19 $7,065 - $8,569
-8 Reduced 0.68%
1,165 $1.22 Million
Q1 2024

May 13, 2024
BUY
$902.69 - $993.35 $13,540 - $14,900
15 Added 1.3%
1,173 $1.13 Million
Q4 2022

Feb 07, 2023
SELL
$705.89 - $766.39 $176,472 - $191,597
-250 Reduced 17.76%
1,158 $835,000
Q2 2022

Aug 15, 2022
SELL
$548.35 - $738.84 $2.32 Million - $3.12 Million
-4,224 Reduced 75.0%
1,408 $832,000
Q1 2022

May 05, 2022
BUY
$595.12 - $698.43 $2.52 Million - $2.96 Million
4,232 Added 302.29%
5,632 $3.93 Million
Q1 2021

May 14, 2021
BUY
$446.73 - $548.2 $625,422 - $767,480
1,400 New
1,400 $662,000
Q3 2020

Nov 12, 2020
SELL
$544.75 - $658.21 $220,079 - $265,916
-404 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$493.32 - $643.92 $47,358 - $61,816
-96 Reduced 19.2%
404 $252,000
Q1 2020

May 12, 2020
SELL
$336.18 - $494.43 $355,678 - $523,106
-1,058 Reduced 67.91%
500 $244,000
Q4 2019

Feb 10, 2020
SELL
$274.13 - $376.51 $25,494 - $35,015
-93 Reduced 5.63%
1,558 $585,000
Q2 2019

Aug 08, 2019
BUY
$299.6 - $414.82 $494,639 - $684,867
1,651 New
1,651 $517,000
Q4 2018

Feb 13, 2019
SELL
$335.82 - $403.04 $218,283 - $261,976
-650 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$351.14 - $408.51 $228,241 - $265,531
650 New
650 $263,000
Q4 2017

Feb 14, 2018
SELL
$358.63 - $469.95 $6.86 Million - $8.99 Million
-19,136 Closed
0 $0
Q3 2017

Nov 13, 2017
BUY
$431.38 - $504.0 $8.25 Million - $9.64 Million
19,136
19,136 $8.56 Million

Others Institutions Holding REGN

# of Institutions
1,531
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Philadelphia Trust CO Portfolio

Follow Philadelphia Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Philadelphia Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Philadelphia Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email